STAAR Surgical Company STAA
NASDAQ
| 10/02/2026 | 07/03/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -10.82% | 0.01% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.82% | 0.01% | |||
| Cost of Revenue | 1.97% | -3.47% | |||
| Gross Profit | -15.19% | 1.26% | |||
| SG&A Expenses | -13.04% | 19.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.58% | 9.61% | |||
| Operating Income | -45.58% | -41.75% | |||
| Income Before Tax | -36.68% | 34.14% | |||
| Income Tax Expenses | -52.63% | -1.53% | |||
| Earnings from Continuing Operations | -30.81% | 54.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.81% | 54.78% | |||
| EBIT | -45.58% | -41.75% | |||
| EBITDA | -36.57% | -35.81% | |||
| EPS Basic | -31.11% | 53.50% | |||
| Normalized Basic EPS | -36.96% | -38.03% | |||
| EPS Diluted | -31.25% | 60.00% | |||
| Normalized Diluted EPS | -36.62% | -38.23% | |||
| Average Basic Shares Outstanding | 0.44% | 0.83% | |||
| Average Diluted Shares Outstanding | -0.10% | 1.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||